STAT3 and alcoholic liver diseases: In animal models of alcoholic liver disease, HSYA regulates the STAT3/NF-κB signaling pathway, inhibits inflammatory cascade reactions, reduces lymphocyte infiltration and inflammatory damage, activates the Keap1/Nrf2 pathway, and reduces oxidative damage (Wang et al., 2024).